Immunomodulatory Properties of Mesenchymal Stromal Cells and Their Therapeutic Consequences for Immune-Mediated Disorders
Authors:
- 13 October 2009
- journal article
- review article
- Published by SAGE Publications in Stem Cells and Development
- Vol. 19 (5) , 607-614
Abstract
Bone marrow-derived mesenchymal stromal cells (MSCs) represent a population of nonhematopoietic cells, which play a crucial role in supporting hematopoiesis and can differentiate into various cell types such as osteocytes, chondrocytes, adipocytes, and myocytes. Due to their differentiation capability, MSCs emerge as promising candidates for therapeutic applications in tissue engineering. In addition, they display immunomodulatory properties that have prompted consideration of their potential use for treatment modalities aimed at the inhibition of immune responses. In this context, MSCs efficiently inhibit maturation, cytokine production, and T-cell stimulatory capacity of dendritic cells (DCs). They also markedly impair proliferation, cytokine secretion, and cytotoxic potential of natural killer cells and T lymphocytes. Furthermore, MSCs are able to inhibit the proliferation of B cells and their capacity to produce antibodies. Various animal models confirm the immunomodulatory properties of MSCs. Thus, administered MSCs prolong the survival of skin and cardiac allografts and ameliorate acute graft-versus-host disease (GVHD) as well as experimental autoimmune encephalomyelitis. Clinical studies enrolling patients with severe acute GVHD reveal that the administration of MSCs results in significant clinical responses. Due to their immunomodulatory capability and their low immunogenicity, MSCs represent promising candidates for the prevention and treatment of immune-mediated diseases.Keywords
This publication has 95 references indexed in Scilit:
- Kidney-Derived Stromal Cells Modulate Dendritic and T Cell ResponsesJournal of the American Society of Nephrology, 2009
- The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repairJournal of Cellular Physiology, 2008
- A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human OrgansCell Stem Cell, 2008
- Immune Regulation by Mesenchymal Stem Cells Derived from Adult Spleen and ThymusStem Cells and Development, 2007
- Mesenchymal stem cells reside in virtually all post-natal organs and tissuesJournal of Cell Science, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statementCytotherapy, 2005
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999
- Mesenchymal stem cellsJournal of Orthopaedic Research, 1991
- HETEROTOPIC TRANSPLANTS OF BONE MARROWTransplantation, 1968